# McLaren Northern Michigan – FDA Inspection, Aug 4, 2026

Source: https://www.keypedia.com/records/fda_inspections/mclaren-northern-michigan/73c6abd5-d4a3-425a-844b-7c90a59e4280
Source feed: FDA_Inspections

> FDA inspection 1329420 of McLaren Northern Michigan, August 04, 2026. 2 citations under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1329420
- Company Name: McLaren Northern Michigan
- Inspection Date: 2026-08-04
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Detroit District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1097340 - 2019-06-12
- FDA Inspection 1025480 - 2017-08-24
- FDA Inspection 929603 - 2015-06-05
- FDA Inspection 811305 - 2012-12-14
- FDA Inspection 701383 - 2010-12-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/mclaren-northern-michigan/8962ed6b-b23c-43f0-b946-207a6a950889

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03